BIO is publishing a weekly pipeline tracker to provide updates on clinical innovation happening in the industry to combat COVID-19. The WHO's COVID-19 Vaccine Tracker and Landscape provides - twice a week - visualization tables of the status and progression of COVID-19 vaccine candidates in the pipeline, as well as links to reports on safety and efficacy.
The innovative pharmaceutical industry is developing new COVID-19 vaccines and adapting existing ones to offer longer, broader, and more durable protection. This includes multi-valent vaccines that can offer protection against more than one variant of COVID-19.
We are developing new medicines to treat symptoms of COVID-19 at every stage of infection. These include antiviral therapies, which aim to stop the virus during early stages of infection, prevent it from copying itself in our cells, or strengthen our body's existing viral defenses.
In addition, we are developing therapies designed to protect people's heart, blood, and lungs from the harmful effects of COVID-19 infection, and medicines that intend to relieve the life-altering symptoms of long COVID.